Assisted living facility provider Geri Care expands its operations, opening a new location at Velachery, marking its 10th facility.

In the realm of Indian healthcare, several significant developments have emerged recently.

Firstly, Novo Nordisk, a global healthcare company, has partnered with Apollo Clinics to establish an Obesity Clinic Program in India. This collaboration aims to address the growing concern of obesity in the country.

Meanwhile, Zydus Therapeutics has reported positive topline results from the EPICS-III Phase 2(b)/3 Trial, a clinical research study conducted by the company. The trial focuses on evaluating the efficacy of a certain treatment for a specific condition.

Elsewhere, the FAST Walk system is being evaluated for its potential in neuromodulation-assisted gait recovery in chronic stroke cases. This system could revolutionize the rehabilitation process for stroke survivors.

Moving on, PharmEasy has published a report highlighting Karnataka, Tamil Nadu, and Maharashtra as the leading dengue hotspots in India. However, the report does not provide specific details about the number of cases in each hotspot or the time period covered by the data.

The Indian Institute of Technology Hyderabad (IIITH) hosted an ABDM 2.0 southern region consultation meeting, organised by the National Health Authority (NHA). The objectives of this meeting were not specified in the report.

In a separate development, Mahajan Imaging & Labs has partnered with Fortis La Femme for women and child healthcare. The specific details about this partnership are yet to be disclosed.

Lastly, the report does not specify the methods used to determine the leading dengue hotspots in India, nor does it mention any other states or regions apart from the three aforementioned.

These new developments and findings underscore the ongoing efforts to improve healthcare services and research in India. As more information becomes available, we will keep you updated.